Enovix Co. (NASDAQ:ENVX – Get Free Report) has earned a consensus rating of “Buy” from the ten analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $21.33.
ENVX has been the subject of several analyst reports. B. Riley upgraded Enovix to a “strong-buy” rating in a report on Tuesday, June 25th. Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price target (down previously from $23.00) on shares of Enovix in a research report on Monday, August 5th. Benchmark initiated coverage on Enovix in a research note on Monday, July 22nd. They set a “buy” rating and a $25.00 price objective on the stock. Oppenheimer restated an “outperform” rating and set a $36.00 target price on shares of Enovix in a report on Monday, August 26th. Finally, Craig Hallum upped their price target on shares of Enovix from $15.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st.
Check Out Our Latest Analysis on ENVX
Institutional Trading of Enovix
Enovix Stock Up 5.6 %
Shares of Enovix stock opened at $8.91 on Wednesday. Enovix has a 52-week low of $5.70 and a 52-week high of $18.68. The company has a debt-to-equity ratio of 0.97, a quick ratio of 3.84 and a current ratio of 3.98. The business’s 50 day simple moving average is $10.95 and its 200 day simple moving average is $10.52. The firm has a market cap of $1.51 billion, a PE ratio of -6.65 and a beta of 1.99.
Enovix (NASDAQ:ENVX – Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The business had revenue of $3.77 million for the quarter, compared to analyst estimates of $3.85 million. Enovix had a negative net margin of 1,434.34% and a negative return on equity of 91.21%. On average, analysts predict that Enovix will post -1.21 earnings per share for the current fiscal year.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Bank Stocks – Best Bank Stocks to Invest In
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- How to Invest in the FAANG Stocks
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.